Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies
- PMID: 17362564
- DOI: 10.1258/096914107780154549
Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies
Abstract
Two equations are given to estimate the risk of a woman having a Down's syndrome pregnancy according to maternal age: one for use in estimating antenatal screening performance and the other for use in estimating an individual woman's risk of having an affected pregnancy. Because Down's syndrome pregnancies have an increased tendency to result in a spontaneous fetal loss, the estimation of a woman's risk of having an affected pregnancy will be dependent on gestational age. The best estimates of the prevalence of Down's syndrome are obtained from information relating to births and can reliably be adjusted to prevalence in early second trimester. The most reliable estimates of risk of a Down's syndrome pregnancy using all the currently used markers apply to early in the second trimester. These risks cannot accurately be adjusted to apply to term, because the first trimester markers have not in general been studied in pregnancies that continue to term. Therefore the early second trimester of pregnancy is the gestational age at which all screening performances should be given for the different antenatal screening programmes for Down's syndrome.
Similar articles
-
Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.Prenat Diagn. 1998 Jun;18(6):585-89. Prenat Diagn. 1998. PMID: 9664604
-
An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies.Hum Reprod Update. 2006 Sep-Oct;12(5):513-8. doi: 10.1093/humupd/dml021. Epub 2006 May 3. Hum Reprod Update. 2006. PMID: 16672245 Review.
-
Local norms of maternal serum alpha-fetoprotein values in early second trimester: a prelude to a Down's syndrome screening programme incorporating maternal serum alpha-fetoprotein values.Singapore Med J. 1991 Apr;32(2):134-7. Singapore Med J. 1991. PMID: 1710394
-
Ductus venosus pulsatility index as an antenatal screening marker for Down's syndrome: use with the Combined and Integrated tests.J Med Screen. 2009;16(3):112-8. doi: 10.1258/jms.2009.009043. J Med Screen. 2009. PMID: 19805751
-
[Prenatal screening for Down's syndrome].Zhonghua Fu Chan Ke Za Zhi. 1997 Nov;32(11):694-7. Zhonghua Fu Chan Ke Za Zhi. 1997. PMID: 9639772 Review. Chinese. No abstract available.
Cited by
-
Rodent models in Down syndrome research: impact and future opportunities.Dis Model Mech. 2017 Oct 1;10(10):1165-1186. doi: 10.1242/dmm.029728. Dis Model Mech. 2017. PMID: 28993310 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical